We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App





AI System Distinguish COVID-19 from Flu and Other Respiratory Diseases in Less Than Three Seconds

By HospiMedica International staff writers
Posted on 06 Nov 2020
A new artificial intelligence (AI) system can help doctors distinguish COVID-19 from flu and other respiratory diseases in less than three seconds. More...


The AI system developed by scientists at Tsinghua University (Beijing, China) identifies the differences in CT scans of patients to accurately distinguish between these illnesses. Amidst the approaching influenza season and the growing threat of a second wave of COVID-19 infections across the world, the AI system will allow healthcare workers to distinguish between the two respiratory illnesses having similar symptoms.

The researchers developed and evaluated the deep learning-based COVID-19 diagnosis system using multi-class multicenter data, which included 11,356 CT scans from 9,025 subjects consisting of COVID-19, CAP, influenza, and non-pneumonia. CAP subjects included in our database were all nonviral CAP. In such a difficult multi-class diagnosis task, the deep convolutional neural network-based system was able to achieve an area under the receiver operating characteristic curve (AUC) of 97.81% for multi-way classification on test cohort of 3,199 scans, AUC of 92.99% and 93.25% on two publicly available datasets, CC-CCII and MosMedData respectively. In a reader study involving five radiologists, the AI system outperformed all the radiologists in more challenging tasks at a speed of two orders of magnitude above them.

Overall, the AI system was comprehensively validated on large multi-class datasets with higher diagnosis performance than human experts in diagnosing COVID-19. Unlike classical black box deep learning approaches, by visualizing the AI system and applying radiomics analysis, it can decode effective representation of COVID-19 on CT imaging, and potentially lead to the discovery of new biomarkers. Radiologists can perform an individualized diagnosis of COVID-19 with the AI system, adding a new driving force to the fight against the global spread of the outbreak.

Related Links:
Tsinghua University


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Pulmonary Ventilator
OXYMAG
Infrared Digital Thermometer
R1B1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.